U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the
Investment Company Act of 1940
<TABLE>
- ---------------------------------------- ------------------------- ------------------- --------------------------------------------
<S> <C> <C>
1. Name and Address of Reporting Person 2. Issuer Name and Ticker 6. Relationship of Reporting Person to Issuer
or Trading Symbol DLNZ (Check all applicable)
____ Director
_X __ 10% Owner
_ _ Officer (give title below)
_____Other (specify below)
_________________________
- ---------------------------------------- --------------------------------------------- --------------------------------------------
- ---------------------------------------- --------------------------------------------- --------------------------------------------
(Last) 3. IRS or Social Security 4. Statement for Month /
(First) (Middle) Number Year
Scantek Medical, Inc. of Reporting Person April 1998
(Voluntary)
- ---------------------------------------- ----------------------------- -------------------------------
- ---------------------------------------- ---------------------------- ----------------------------- -------------------------------
(Street) 5. if Amendment, Date of
321 Palmer Rd Original (Month / Year)
- ---------------------------------------- ---------------------------- ----------------------------- -------------------------------
- ---------------------------------------- ------------------------------------------------------------------------------------------
(City)
(State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or
Denville, NJ 07834 Beneficially Owned
- --------------------- -------------------------------------------------------------------------------------------------------------
- --------------------- -------------- ----------- ----------------------------------- ------------------ ------------ -------------
1. Title of Security 2. 3. 4. Securities Acquired (A) or 5. Amount of 6. Ownership 7. Nature
(Instr. 3) Transaction Trans-actionDisposed of (D) (Instr. 3, 4, Securities Form : Direct of Indirect
Date (Month Code and 5) Beneficially Owned (D) or Indirect Beneficial
/ Day / Year) (Instr. 8) at End of Month (I) (Instr. 4) Ownership
(Instr. 3 and 4) (Instr. 4)
- --------------------- -------------- ----------- ----------------------------------- ------------------ ---------------- -----------
- --------------------- -------------- ------- --- ------------- ------- ------------- ------------------ ---------------- -----------
Code V Amout (A) Price
or (D)
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
Common Stock 9/30/97 J 2,000,000 A $2,000 2,000,000 D
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
- --------------------- -------------- ------- --- ------------- ------- ------------- ----------------- ---------------- ------------
</TABLE>
<TABLE>
<CAPTION>
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g. puts, calls, warrants, options, covertible securities)
- ----------- ------------ --------- ---------- ------------- ------------ ------------- ------------- ----------- ---------- --------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
1.Title of 2.Conversion 3.Trans- 4.Trans- 5.Number of 6. Date 7.Title and 8. Price of 9.Number 10. 11.
Derivative or action action Derivative Exercisable Amount of Derivative of Ownership Nature
Security Exercise Date Code Securities and Date Underlying Security Derivative Form of of
(Instr. 3) Price of (Month (Instr. Acquired (A) Expiation Securities (Instr. 5) Securities Derivative Indirect
Derivative /Day/ 8) or Disposed (Month (Instr. 3 Beneficially Security: Bene
Security Year) of (D) and /Day/ and 4) Owned at Direct ficial
Instr. 3, 4, Year) End of (D) or (Ownership
and 5) Month Indirect Instr.4)
(Instr. (I)
4) (Instr.
4)
- ----------- ----------- --------- ---------- --------------- ----------- ------------- ------------- ----------- --------- ---------
Date Expir Title Amount/
Code V (A) (D) Exer ation #of
cisabl Date Shares
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
- ----------- ---------- --------- ------ --- --------- ------- ---- ----- ------ ------ --------- ------------- ---------- ----------
</TABLE>
Explanation of Responses
On September 30, 1997 the Company acquired the assets of Health Technologies
International, Inc. ('HTI'). Scantek paid par value for its acquisition of the
Company's Common stock, and through its acquisition of HTI the Company acquired
a license from Scantek to manufacture certain products in Singapore and Chile.
For Scantek
By: /s/ Zsigmund Sagi 4/2/97
Signature of Reporting Person Date
** Intentional Misstatements or omissions of facts
constitute Federal Criminal Violations ** See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
